NHI.no
Annonse
Informasjon

Helicobacter pylori

Helicobacter pylori (Hp) er en bakterie som kan forekomme i slimhinnen i magesekken. Infeksjon med Hp er den viktigste årsaken til magesårsykdommen.

Helicobacter pylori (Hp) er en bakterie som kan forekomme i slimhinnen i magesekken.

Sist oppdatert:

29. apr. 2022

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Helicobacter pylori . Referanselisten for dette dokumentet vises nedenfor

  1. Smittervernveilederen. Helicobacter pylori-infeksjon - veileder for helsepersonell. Folkehelseinstituttet, sist oppdatert 27.10.2023. Siden lest 15.05.2024 fhi.no
  2. Lamont JT. Bacteriology and epidemiology of Helicobacter pylori infection. UpToDate, last updated Aug 4, 2022. Siden lest 22.05.2024 UpToDate
  3. Helsedirektoratet. Antibiotika i primærhelsetjenesten. Sist oppdatert 16. november 2021. www.helsedirektoratet.no
  4. Lamont JT. Indications and diagnostic tests for Helicobacter pylori infection in adults. UpToDate, last updated Jul 13, 2023. UpToDate
  5. Best LM, Takwoingi Y, Siddique S, et al. Non-invasive diagnostic tests for Helicobacter pylori infection. Cochrane Database Syst Rev. 2018;(3):CD012080. Cochrane (DOI)
  6. Moayyedi PM, Lacy BE, Andrews CN, et al. ACG and CAG clinical guideline: management of dyspepsia. Am J Gastroenterol. 2017 Jul;112(7):988-1013. PubMed
  7. Chey WD, Leontiadis GI, Howden CW, et al. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2017 Feb;112(2):212-39. PubMed
  8. Ford AC, Gurusamy KS, Delaney B, Forman D, Moayyedi P. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people. Cochrane Database Syst Rev. 2016;4(4):CD003840. Published 2016 Apr 19. The Cochrane Library
  9. Gisbert JP, Khorrami S, Carballo F et. al. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. Cochrane Database Syst Rev. 2004;(2):CD004062. PMID: 15106235 PubMed
  10. Zhao B, Zhao J, Cheng WF, et al. Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia: a meta-analysis of randomized controlled studies with 12-month follow-up. J Clin Gastroenterol. 2014;48(3):241-247. PubMed
  11. Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut 2012; 61:646. Gut
  12. Moayyedi P, Lacy BE, Andrews CN, et al. ACG and CAG Clinical Guideline: Management of Dyspepsia. Am J Gastroenterol 2017; 112:988. PubMed
  13. Kahrilas PJ. Medical management of gastroesophageal reflux disease in adults. UpToDate, last updated Nov 29, 2021. UpToDate
  14. Lamont JT. Association between Helicobacter pylori infection and gastrointestinal malignancy. UpToDate, last updated Jan 25, 2022. UpToDate
  15. Lee YC, Chiang TH, Chou CK, et al. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. Gastroenterology. 2016;150(5):1113-1124.e5. PMID: 26836587 PubMed
  16. Helsedirektoratet. Nasjonal faglig retningslinje for bruk av antibiotika i sykehus. Sist oppdatert 01.03.2022. www.helsedirektoratet.no
  17. Ren Q, Yan X, Zhou Y, Li WX. Periodontal therapy as adjunctive treatment for gastric Helicobacter pylori infection. Cochrane Database of Syst Rev 2016, Issue 2. Art. No.: CD009477. DOI: 10.1002/14651858.CD009477.pub2. DOI
  18. Szajewska H, Horvath A, Piwowarczyk A. Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment. Aliment Pharmacol Ther 2010; 32: 1060-79. PubMed
  19. Mišak Z, Hojsak I, Homan M. Review: Helicobacter pylori in pediatrics. Helicobacter. 2019;24 Suppl 1:e12639.
Annonse
Annonse